In CD8+ cells, the expression levels of PD1 (+), LAG3 (+), or PD1 (+) LAG3 (+) all showed a decreasing trend after treatment compared with untreated DLBCL patients ( Figure 3(b) ).
← all excerpts
LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients.
1
—
—